AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

Researchers provide a conceptual overview of liver vasomics, including the classification of vascular phenotypes in the liver ...

The biotech unveiled a new research program in alpha-1 antitrypsin deficiency, a disease that’s also a focus for rival Beam Therapeutics.

Prime Medicine's program leverages the Company's universal liver lipid nanoparticle (LNP) to edit the E342K (Pi*Z) mutation in the SERPINA1 gene, the prevalent disease-causing mutation in AATD, ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

By Chioma Obinna The Federal Government has appointed Prof. Olusegun Sylvester Ojo as the pioneer Chief Medical Director of the FUTA Teaching Hospital, Akure, Ondo State with effect from March 5, 2025 ...

HEFEI – Chinese scientists and their counterparts from Singapore have developed a highly accurate scoring system to predict the risk of recurrence for a serious form of liver cancer called ...